Probiotic R-2487 for Sjogren's Syndrome
(R-2487-SjD-01 Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
The goal of this study is to determine the safety and tolerability of orally taken probiotic (R-2487) in patients with Sjogren's Syndrome.
Patients will take an oral dosage of probiotic (R-2487) and physicians will assess and measure their Sjogren's Syndrome. Blood and fecal evaluations of inflammation and assessment of probiotic (R-2487) on fecal level will also be measured.
Are You a Good Fit for This Trial?
This trial is for adults diagnosed with Sjögren's Syndrome who can give consent. Participants must use birth control if they could have children, and women must test negative for pregnancy. Steroid doses should be stable, and no other probiotics are allowed during the study.Inclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- R-2487
Trial Overview
The study tests an oral probiotic called R-2487 to see if it is safe and well-tolerated in people with Sjögren's Syndrome. Researchers will monitor symptoms and check blood and stool samples for inflammation.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Probiotic
Find a Clinic Near You
Who Is Running the Clinical Trial?
Rise Therapeutics LLC
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.